KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Liabilities (2018 - 2025)

ClearPoint Neuro's Total Liabilities history spans 13 years, with the latest figure at $44.5 million for Q3 2025.

  • For Q3 2025, Total Liabilities rose 297.45% year-over-year to $44.5 million; the TTM value through Sep 2025 reached $44.5 million, up 297.45%, while the annual FY2024 figure was $13.8 million, 35.78% down from the prior year.
  • Total Liabilities for Q3 2025 was $44.5 million at ClearPoint Neuro, up from $43.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $44.5 million in Q3 2025 and bottomed at $10.1 million in Q1 2025.
  • The 5-year median for Total Liabilities is $19.1 million (2024), against an average of $21.4 million.
  • The largest YoY upside for Total Liabilities was 297.45% in 2025 against a maximum downside of 47.08% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $16.8 million in 2021, then rose by 10.77% to $18.6 million in 2022, then rose by 15.51% to $21.5 million in 2023, then crashed by 35.78% to $13.8 million in 2024, then soared by 222.34% to $44.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Total Liabilities are $44.5 million (Q3 2025), $43.1 million (Q2 2025), and $10.1 million (Q1 2025).